Purchase Order HHSD2002016M91408P
Award Date
9/1/16
Potential Completion Date
2/28/17
Potential Value
$149K
Federal Agency
CDC Pittsburgh
Awardee
Base Pair Biotechnologies Inc.
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pearland, TX 77584, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $125,000.04 firm-fixed price purchase order awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Base Pair Biotechnologies Inc., a for-profit company that provides custom aptamer development services and products. The contract is for aptamer development services, and does not have a set-aside designation. Through prior contracts and grants, Base Pair Biotechnologies has provided research and development services related to...
This is a $199,565.00 firm fixed price definitive contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Base Pair Biotechnologies Inc., a for-profit company that provides custom aptamer development services and products to the federal government. The contract was awarded on September 13, 2013 with a completion date of June 12, 2014. The contract does not have a set-aside designation. Through this contract, Base Pair...
This is a $300,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Base Pair Biotechnologies Inc., a for-profit company that provides custom aptamer development services and products to the federal government. The contract is for the "Development and Validation of Non-Mouse Reagents to Enable Preclinical Development of Novel Therapeutics", which was one of the research topics identified in the...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc., a privately held company specializing in oligonucleotide-based tools. The contract, valued at $87,500.00, is for the provision of laboratory equipment. Biosearch Technologies has a history of providing laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support the CDC, Department of Defense, and National...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC), a component of the Department of Health and Human Services (HHS), to Biosearch Technologies, Inc. (dba Biosearch Technologies). The $473,206.40 contract is for the provision of a SARS-COV-2 Influenza Multiplex Assay, which supports disease surveillance, diagnostic testing, public health research, and emergency response efforts related to pathogens such as COVID-19. Biosearch Technologies,...
This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT), a manufacturer of nucleic acid products, for the supply of PROBEKITS. The $137,179.84 firm fixed price purchase order does not have a set-aside designation. IDT is a major supplier of oligonucleotides, probes, reagents, and other products to federal agencies like the National Institutes of Health, Department of Defense,...
This is a firm fixed price delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc. for $98,400.00. The contract, which has no set-aside designation, is for the provision of laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support disease surveillance, diagnostic testing, public health research, and emergency response efforts related to pathogens like influenza, COVID-19, Ebola, and Brucella....
This is a federal contract award to Biosearch Technologies, Inc. LGC Biosearch Technologies Division, a privately-held company that specializes in the design, development, and manufacture of oligonucleotide-based tools. The contract, awarded by the Centers for Disease Control and Prevention (CDC) under the Department of Health and Human Services, is an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with a potential value of $145,400.00. It is a firm fixed price contract with no...
This is a firm-fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Pacific Biosciences of California, Inc. for $84,000.00. The contract is for a service plan and has no set-aside designation. Pacific Biosciences is the original equipment manufacturer for their proprietary single molecule, real-time (SMRT) DNA/RNA sequencing technology. This contract award is likely part of Pacific Biosciences' broader work providing specialized sequencing...
This is a firm fixed price Blanket Purchase Agreement (BPA) call order awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc. for $164,625.00. The contract is for the delivery of laboratory kits, with no set-aside designation. Biosearch Technologies, through its LGC Biosearch Technologies division, has provided a variety of laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support the CDC's public health research and...